Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Jan. 2, 2018. Vito Pirrera & John Jordon.

Executive Summary

Check out what Vantage Consulting Group's Vito Pirrera and John Jordon had to say about companies using machine vision for inspecting high-throughput medical device parts.

"Machine vision [is] a way to improve quality and revenue. Although it will require a capital investment, that investment will be defrayed by additional efficiency, revenue, brand equity, relationship quality, and human health and safety. And with one vision system versus many human inspectors, you’ll also be able to move inspectors to roles where the limits of human eyesight don’t jeopardize business performance – or lives." –Vito Pirrera, cofounder and executive VP, & John Jordon, VP of business strategies, Vantage Consulting Group

> Find out more: Machine Vision’s Promise For Medical Device Quality

Click here for a free trial of Medtech Insight

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121970

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel